Sign In
Buy EVGN
$0.599
+0.0089 (+1.51%)
At Close: Jun 03, 2026
Evogene to Participate in CRISPR-IL Consortium to Provide End-to-End Artificial Intelligence System for Genome-Editing
11:00am, Wednesday, 03'rd Jun 2020
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading computational biology company targeting to revolutionize life-science product development across several market segments, announced today its par
Evogene Posts Q1 Results, Suffers 67% YoY Revenue Decline
07:31pm, Tuesday, 26'th May 2020Evogene Reports First Quarter 2020 Financial Results
11:00am, Tuesday, 26'th May 2020
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading computational biology company targeting to revolutionize life-science product development across several market segments, announced today its fin
Evogene Launches Its New Branding to Reflect the Company's Expanded Vision and New Business Model
11:00am, Wednesday, 20'th May 2020
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading computational biology company targeting to revolutionize life-science product development across several market segments, announces today its reb
Evogene Financial Results and Earnings Announcement Schedule for the First Quarter of 2020
11:00am, Thursday, 07'th May 2020
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading biotechnology company aiming to revolutionize the development of novel products for life-science based industries by utilizing cutting edge compu
Evogene Sends Letter to Shareholders, Colleagues, Business Partners
11:35am, Tuesday, 05'th May 2020Evogene Publishes Letter to Shareholders
11:00am, Tuesday, 05'th May 2020
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading biotechnology company aiming to revolutionize the development of novel products for life-science based industries, by utilizing cutting edge comp
Evogene Files Annual Report for the Year Ended December 31, 2019
11:00am, Thursday, 30'th Apr 2020
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading biotechnology company aiming to revolutionize the development of novel products for life-science based industries, announced today that it has filed
Corteva Agriscience And AgPlenus Announce Collaboration For Development Of Novel Herbicides
12:17pm, Wednesday, 25'th Mar 2020Corteva Agriscience and AgPlenus Announce Collaboration for the Development of Novel Herbicides
12:00pm, Wednesday, 25'th Mar 2020
Corteva Agriscience (NYSE: CTVA), a leading pure-play agriculture company, and AgPlenus, a subsidiary of Evogene Ltd., (NASDAQ: EVGN) (TASE: EVGN), today announced that they have entered into a multi-
The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates
07:36am, Wednesday, 18'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 17) …
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 9.) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Enzo Bi
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit hit 52-week highs March 5.) * Arcus Biosciences Inc (NYSE: RCUS) * Arcturu
The Daily Biotech Pulse: Trevana Pain Drug Resubmission Accepted For Review, Can-Fite To Explore Treatment For COVID-19
01:05pm, Thursday, 05'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 4) * 89bio Inc (NASDAQ: ETNB) * Arcus Biosciences In
